Ian C. Read, currently head of Pfizer’s global biopharmaceutical operations, has been appointed president, chief executive officer and director of Pfizer. Mr. Read succeeds Jeffrey B. Kindler, who has retired from the company. Mr. Kindler commented, “My nearly nine years at Pfizer, particularly the last four and a half as CEO, have been extremely exciting and rewarding. I feel our team can proudly boast of some transformational accomplishments. However, the combination of meeting ...